{
  "Variants Include": [
    {
      "Gene": "SNCA",
      "variants": [
        {
          "HGVS": "NM_002193.3:c.90G>C",
          "cDNA Change": {
            "transcript": "NM_002193.3",
            "ref": "G",
            "alt": "C",
            "position": "90"
          },
          "Protein Change": {
            "ref": "A",
            "alt": "P",
            "position": "30"
          },
          "Description in input context": "A30P mutation"
        },
        {
          "HGVS": "NM_002193.3:c.158C>A",
          "cDNA Change": {
            "transcript": "NM_002193.3",
            "ref": "C",
            "alt": "A",
            "position": "158"
          },
          "Protein Change": {
            "ref": "A",
            "alt": "T",
            "position": "53"
          },
          "Description in input context": "A53T mutation"
        },
        {
          "HGVS": "NM_002193.3:c.136G>A",
          "cDNA Change": {
            "transcript": "NM_002193.3",
            "ref": "G",
            "alt": "A",
            "position": "136"
          },
          "Protein Change": {
            "ref": "E",
            "alt": "K",
            "position": "46"
          },
          "Description in input context": "E46K mutation"
        }
      ]
    }
  ],
  "Described Disease": {
    "Described Disease": "Parkinson's disease",
    "MONDO": "MONDO:0004981"
  },
  "Experiment Method": [
    {
      "Assay Method": "Cell viability and protein aggregation assay",
      "Material used": {
        "Material Source": "Cell line",
        "Material Name": "SH-SY5Y",
        "Description": "SH-SY5Y cells overexpressing wild-type and mutant SNCA (A30P, A53T, E46K) were treated with rotenone and maneb."
      },
      "Readout type": "Quantitative",
      "Readout description": [
        {
          "Variant": "NM_002193.3:c.90G>C",
          "Conclusion": "Abnormal",
          "Molecular Effect": "Increased toxicity and aggregation",
          "Result Description": "A30P mutation showed enhanced cell death and protein aggregation compared to wild-type."
        },
        {
          "Variant": "NM_002193.3:c.158C>A",
          "Conclusion": "Abnormal",
          "Molecular Effect": "Increased toxicity and aggregation",
          "Result Description": "A53T mutation exhibited significant cell death and protein aggregation."
        },
        {
          "Variant": "NM_002193.3:c.136G>A",
          "Conclusion": "Abnormal",
          "Molecular Effect": "Increased toxicity and aggregation",
          "Result Description": "E46K mutation demonstrated elevated cell death and aggregation."
        }
      ],
      "Biological replicates": {
        "Biological replicates": "N.D.",
        "Description": "Not described in the literature."
      },
      "Technical replicates": {
        "Technical replicates": "N.D.",
        "Description": "Not described in the literature."
      },
      "Basic positive control": {
        "Basic positive control": "Yes",
        "Description": "Wild-type SNCA was used as a baseline control."
      },
      "Basic negative control": {
        "Basic negative control": "Yes",
        "Description": "Empty vector transfection was used as a negative control."
      },
      "Validation controls P/LP": {
        "Validation controls P/LP": "Yes",
        "Counts": "3"
      },
      "Validation controls B/LB": {
        "Validation controls B/LB": "N.D.",
        "Counts": "0"
      },
      "Statistical analysis method": {
        "Statistical analysis method": "N.D."
      },
      "Threshold for normal readout": {
        "Threshold for normal readout": "Cell viability above 80% with minimal aggregation.",
        "Source": "Custom"
      },
      "Threshold for abnormal readout": {
        "Threshold for abnormal readout": "Cell viability below 50% with significant aggregation.",
        "Source": "Custom"
      },
      "Approved assay": {
        "Approved assay": "Yes"
      }
    }
  ]
}